PITstop GLP-1 care pathway
The care pathway offers a structured approach to assessing and initiating GLP-1 therapy and includes guidance for the initial 6-month follow-up and audit requirements. The care pathway encorporates details of the licensed GLP-1s in the UK, including starting dose and dose titration (if required). Updated May 2024